Yutaka Kawano

Tokushima, JP 
Clinical Trials:Currently Recruiting for 1 Trial
Tokushima, JP 

Overview

Yutaka Kawano practices practicing medicine in Tokushima, Japan.

His clinical expertise encompasses Prolidase Deficiency, Juvenile Dermatomyositis, Mouth Sores, Tissue Biopsy, and Thymectomy.

He is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Tokushima, Japan
Other Locations
Sapporo, Japan
Saitama, Japan
Ishikari, 0610293, Japan
Shintoshin, 3308777, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Completed
Publish Date: October 07, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
View 1 Less Clinical Trial

84 Total Publications

Prophylactic effects of Acanthopanax senticosus Harms on the development of colitis in mice.
Prophylactic effects of Acanthopanax senticosus Harms on the development of colitis in mice.
Journal: Biomedical reports
Published: January 15, 2026

Frequently Asked Questions about Yutaka Kawano

Is Yutaka Kawano a top-rated expert for Prolidase Deficiency?

MediFind is an objective health platform that identifies experts based on real-world data. Yutaka Kawano is classified as an Experienced expert for Prolidase Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yutaka Kawano participate in research or clinical trials?

Yes. Yutaka Kawano has published 84 articles and abstracts on conditions like Prolidase Deficiency. You can view a list of Yutaka Kawano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kawano's expertise for a condition
ConditionClose
        View All 51 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile